14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $43.33 $52.87 Friday, 3rd May 2024 BMY stock ended at $43.99. This is 0.664% more than the trading day before Thursday, 2nd May 2024. During the day the stock fluctuated 1.48% from a day low at $43.69 to a day high of $44.33.
90 days $43.33 $55.03
52 weeks $43.33 $69.10

Historical Bristol-Myers Squibb Company prices

Date Open High Low Close Volume
Mar 11, 2016 $65.18 $65.59 $64.54 $64.96 7 106 400
Mar 10, 2016 $66.17 $66.26 $64.48 $64.94 5 988 100
Mar 09, 2016 $66.66 $66.68 $64.95 $65.54 5 431 200
Mar 08, 2016 $66.11 $66.36 $65.73 $66.26 6 030 100
Mar 07, 2016 $64.50 $66.63 $64.45 $66.49 6 943 700
Mar 04, 2016 $65.00 $65.29 $64.17 $64.71 7 102 300
Mar 03, 2016 $64.49 $65.24 $63.64 $65.00 8 190 000
Mar 02, 2016 $64.18 $65.09 $63.71 $64.90 6 148 700
Mar 01, 2016 $62.31 $64.24 $61.92 $64.22 5 192 800
Feb 29, 2016 $62.26 $62.73 $61.92 $61.93 7 238 000
Feb 26, 2016 $63.35 $63.58 $62.24 $62.25 5 343 700
Feb 25, 2016 $62.63 $63.06 $62.30 $63.03 4 499 900
Feb 24, 2016 $61.84 $62.36 $60.83 $62.23 4 825 800
Feb 23, 2016 $63.28 $63.35 $62.02 $62.07 6 251 500
Feb 22, 2016 $63.90 $64.42 $63.33 $63.70 5 811 100
Feb 19, 2016 $62.92 $64.54 $62.91 $63.80 5 857 200
Feb 18, 2016 $63.95 $64.02 $62.91 $63.32 6 304 100
Feb 17, 2016 $62.89 $64.02 $61.96 $63.92 6 946 400
Feb 16, 2016 $62.72 $62.72 $61.35 $62.18 7 740 900
Feb 12, 2016 $60.20 $60.41 $59.16 $60.20 5 960 700
Feb 11, 2016 $59.88 $60.25 $58.94 $59.52 6 564 200
Feb 10, 2016 $61.25 $62.42 $60.92 $61.08 5 930 700
Feb 09, 2016 $60.27 $61.98 $60.03 $61.02 6 321 400
Feb 08, 2016 $59.04 $61.17 $58.77 $60.72 10 639 900
Feb 05, 2016 $59.75 $60.06 $58.99 $59.63 7 091 100
Click to get the best stock tips daily for free!

About Bristol-Myers Squibb Company

Bristol-Myers Squibb Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple myeloma; Eliquis, an oral inhibitor for reduction in risk of stroke/systemic embolism in NVAF, and for th... BMY Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT